Standard Standard

The role of serotonin in personality interference: tryptophan depletion impairs the identification of neuroticism in the face. / Ward, Robert; Sreenivas, Shubha; Read, Judi et al.
In: Psychopharmacology, Vol. 234, No. 14, 07.2017, p. 2139-2147.

Research output: Contribution to journalArticlepeer-review

HarvardHarvard

APA

CBE

MLA

VancouverVancouver

Ward R, Sreenivas S, Read J, Saunders K, Rogers RD. The role of serotonin in personality interference: tryptophan depletion impairs the identification of neuroticism in the face. Psychopharmacology. 2017 Jul;234(14):2139-2147. Epub 2017 May 9. doi: 10.1007/s00213-017-4619-4

Author

Ward, Robert ; Sreenivas, Shubha ; Read, Judi et al. / The role of serotonin in personality interference : tryptophan depletion impairs the identification of neuroticism in the face. In: Psychopharmacology. 2017 ; Vol. 234, No. 14. pp. 2139-2147.

RIS

TY - JOUR

T1 - The role of serotonin in personality interference

T2 - tryptophan depletion impairs the identification of neuroticism in the face

AU - Ward, Robert

AU - Sreenivas, Shubha

AU - Read, Judi

AU - Saunders, Kate

AU - Rogers, Robert D.

PY - 2017/7

Y1 - 2017/7

N2 - Serotonergic mechanisms mediate the expression of personality traits linked to vulnerability to psychological illness such as impulsivity, aggression and anxiety; and modulate the identification of emotional expressions in the face as well as emotional learning about broader classes of appetitive and aversive signals. Faces with neutral expressions signal a variety of socially-relevant information, such that inferences about the big-five personality traits, including Neuroticism, Extraversion, and Agreeableness, can be accurately made on the basis of emotionally neutral facial photographs. Given the close link between Neuroticism and psychological distress, anxiety and depression, we investigated the effects of diminished central serotonin activity (achieved by tryptophan depletion) upon the accuracy of 52 healthy (non-clinical) adults' discriminations of personality from facial characteristics. All participants were able to discriminate reliably four of the big-five traits, including Neuroticism. However, the tryptophan-depleted participants were specifically less accurate in discriminating Neuroticism than the matched non-depleted participants. These data suggest that central serotonin activity modulates the identification of, not only negative facial emotional expression, but a broader class of signals about personality characteristics linked to psychological distress.

AB - Serotonergic mechanisms mediate the expression of personality traits linked to vulnerability to psychological illness such as impulsivity, aggression and anxiety; and modulate the identification of emotional expressions in the face as well as emotional learning about broader classes of appetitive and aversive signals. Faces with neutral expressions signal a variety of socially-relevant information, such that inferences about the big-five personality traits, including Neuroticism, Extraversion, and Agreeableness, can be accurately made on the basis of emotionally neutral facial photographs. Given the close link between Neuroticism and psychological distress, anxiety and depression, we investigated the effects of diminished central serotonin activity (achieved by tryptophan depletion) upon the accuracy of 52 healthy (non-clinical) adults' discriminations of personality from facial characteristics. All participants were able to discriminate reliably four of the big-five traits, including Neuroticism. However, the tryptophan-depleted participants were specifically less accurate in discriminating Neuroticism than the matched non-depleted participants. These data suggest that central serotonin activity modulates the identification of, not only negative facial emotional expression, but a broader class of signals about personality characteristics linked to psychological distress.

KW - Serotonin

KW - Personality

KW - Neuroticism

KW - Psychological distress

U2 - 10.1007/s00213-017-4619-4

DO - 10.1007/s00213-017-4619-4

M3 - Article

VL - 234

SP - 2139

EP - 2147

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 14

ER -